logo
  • About us
    • The Company in brief
    • Strategy
    • Market
    • Organisation
      • Management
      • Board of Directors
  • Our Drug Projects
    • Science
    • Pipeline
    • Disorders
      • Primary Biliary Cholangitis (PBC)
      • Hepatic Encephalopathy (HE)
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
    • Calendar
    • Press Releases
  • Media
    • Press Releases
    • Subscribe
  • Contact

Financial Reports and Presentations

All categories
  • Annual reports
2020
  • 2021
  • All years
All languages
  • English
  • Swedish
2020

Årsredovisning 2019

Read more
2020

Annual Report 2019

Read more
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
    • Calendar
    • Press Releases

IR contact

Magnus Doverskog
Magnus Doverskog
Chief Executive Officer
+46 (0)730 39 20 52
magnus.doverskog@umecrine.se

Subscribe

CONTACT

Magnus Doverskog
Chief Executive Officer
Phone +46 73 039 20 52
magnus.doverskog@umecrine.se

All contacts

VISITING ADDRESS

Karolinska Institutet Science Park
Fogdevreten 2
SE – 171 65 Solna
Sweden

COMPANY INFORMATION

Umecrine Cognition AB
Registered office in Umeå
Reg no 556698-3655

  • Cookies
  • Privacy Policy